Brain Cancer Trial, Recruiting NCT07660458 Sponsor: West China Hospital Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT07660458
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For children:

  • The child has been diagnosed with medulloblastoma (a type of brain tumor) that has come back, confirmed by a scan or tissue sample
  • The child is 18 years old or younger at the time of joining the trial
  • The child is currently receiving active treatment for the returned cancer
  • The child is expected to live for at least 3 months

For parents/caregivers:

  • The parent or caregiver is the main person responsible for managing the child's medications and treatment appointments
  • The parent or caregiver is at least 18 years old
  • The parent or caregiver can read and understand study materials written in English
  • The parent or caregiver is willing to fill out study questionnaires and take part in assessments

Who may not be able to join:

  • The child is only receiving comfort or end-of-life (hospice) care, rather than active treatment
  • The parent or caregiver has a serious mental health condition or difficulty with thinking or understanding that would prevent them from giving informed consent or completing questionnaires
  • The child is already taking part in another clinical trial that could affect how adherence to treatment is measured

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 18980606446

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
West China Hospital
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
30 June 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Overall Treatment Adherence Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov